Estrone and estradiol C-16 derivatives as inhibitors of type 1 17β-hydroxysteroid dehydrogenase

被引:26
作者
Poirier, D
Chang, H
Azzi, A
Boivin, RP
Lin, SX
机构
[1] CHU Laval, Oncol & Mol Endocrinol Res Ctr, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Quebec City, PQ G1V 4G2, Canada
关键词
steroid; inhibitor; hydroxysteroid dehydrogenase; 17; beta-HSD; cancer;
D O I
10.1016/j.mce.2005.10.017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Three series of steroid derivatives, enones 1, enols 2 and saturated alcohols 3, were easily synthesized from estrone according to a sequence of three reactions: an aldol condensation with an aromatic aldehyde (Ra-gCHO) to afford 1, the carbonyl reduction of 1 to obtain the enol 2, and the double bond reduction of 2 to give 3 with the Ra-g group 16 beta-oriented. All compounds were tested as inhibitors of type 117 beta-HSD. The inhibitory potency increases in the following order 1 < 2 < 3, suggesting that the presence of a flexible 16 beta-methylene group allows a better positioning of the aryl moiety. With an IC50 of 0.8 mu M, the 16 beta-benzyl-E-2 (3a) is the best inhibitor in this series. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:236 / 238
页数:3
相关论文
共 11 条
[1]   Development and validation of a genetic algorithm for flexible docking [J].
Jones, G ;
Willett, P ;
Glen, RC ;
Leach, AR ;
Taylor, R .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) :727-748
[2]   Intracrinology:: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease [J].
Labrie, F ;
Luu-The, V ;
Lin, SX ;
Simard, J ;
Labrie, C ;
El-Alfy, M ;
Pelletier, G ;
Bélanger, A .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (01) :1-16
[3]   The role of 17 beta-hydroxy steroid dehydrogenases [J].
Mindnich, R ;
Möller, G ;
Adamski, J .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 218 (1-2) :7-20
[4]   17 beta-hydroxysteroid dehydrogenase: Inhibitors and inhibitor design [J].
Penning, TM .
ENDOCRINE-RELATED CANCER, 1996, 3 (01) :41-56
[5]   Inhibitors of 17β-hydroxysteroid dehydrogenases [J].
Poirier, D .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (06) :453-477
[6]   A concerted, rational design of type 1 17β-hydroxysteroid dehydrogenase inhibitors:: estradiol-adenosine hybrids with high affinity [J].
Qiu, W ;
Campbell, RL ;
Gangloff, A ;
Dupuis, P ;
Boivin, RP ;
Tremblay, MR ;
Poirier, D ;
Lin, SX .
FASEB JOURNAL, 2002, 16 (13) :1829-+
[7]   Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers [J].
Smith, HJ ;
Nicholls, PJ ;
Simons, C ;
Le Lain, R .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (05) :789-824
[8]  
THOMAS JL, 1983, J BIOL CHEM, V258, P1500
[9]   Chemical synthesis of 16β-propylaminoacyl derivatives of estradiol and their inhibitory potency on type 1 17β-hydroxy steroid dehydrogenase and binding affinity on steroid receptors [J].
Tremblay, MR ;
Lin, SX ;
Poirier, D .
STEROIDS, 2001, 66 (11) :821-831
[10]   Overview of a rational approach to design type I 17β-hydroxysteroid dehydrogenase inhibitors without estrogenic activity:: Chemical synthesis and biological evaluation [J].
Tremblay, MR ;
Poirier, D .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 66 (04) :179-191